Subscribe
shutterstock_1826477633_hjbc
HJBC / Shutterstock.com
2 August 2022MedtechStaff Writer

Medtech firm faces lawsuit over COVID–19 design

Leading healthcare tech company accused of infringing COVID-19 test design | Cellex has asked court for injunctive relief | Siemens.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
Vaccine makers hit back against patent claims
28 July 2022   German biotech and its US big pharma partner file counter complaint | Under-fire pair say they didn’t infringe patents | Claims reject earlier suit as an attempt to profit through legal threats.
Big Pharma
CureVac sues BioNTech over mRNA technology
7 July 2022   Germany-based CureVac has accused BioNTech of infringing four patents related to messenger ribonucleic acid technology.
Medtech
Medtech firm takes ex-employee to court over alleged trade secrets breach
23 February 2023   California-based company claims materials engineer emailed himself confidential information | Trade secrets related to artificial heart valve materials.


Editor's picks

Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024

Editor's picks

Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024

More on this story

Medtech
Medtech firm takes ex-employee to court over alleged trade secrets breach
23 February 2023   California-based company claims materials engineer emailed himself confidential information | Trade secrets related to artificial heart valve materials.
Big Pharma
CureVac sues BioNTech over mRNA technology
7 July 2022   Germany-based CureVac has accused BioNTech of infringing four patents related to messenger ribonucleic acid technology.
Big Pharma
Vaccine makers hit back against patent claims
28 July 2022   German biotech and its US big pharma partner file counter complaint | Under-fire pair say they didn’t infringe patents | Claims reject earlier suit as an attempt to profit through legal threats.

More on this story

Medtech
Medtech firm takes ex-employee to court over alleged trade secrets breach
23 February 2023   California-based company claims materials engineer emailed himself confidential information | Trade secrets related to artificial heart valve materials.
Big Pharma
CureVac sues BioNTech over mRNA technology
7 July 2022   Germany-based CureVac has accused BioNTech of infringing four patents related to messenger ribonucleic acid technology.
Big Pharma
Vaccine makers hit back against patent claims
28 July 2022   German biotech and its US big pharma partner file counter complaint | Under-fire pair say they didn’t infringe patents | Claims reject earlier suit as an attempt to profit through legal threats.

More features

President Trump 2.0: Five major areas to watch
Startup CFO’s betrayal is a lesson in preparing for the worst
Sandoz lands reduced antitrust award of $70m
New president’s to-do list: Patent bills, non-competes, USPTO director?
Sanofi subsidiary fends off $450m trade secrets case
Regulatory expert joins White & Case
Teva faces $500m fine for antitrust breaches over MS drug
UK Budget: A missed opportunity?